| Weight | 1 lbs | 
|---|---|
| Dimensions | 9 × 5 × 2 in | 
| host | rabbit | 
| isotype | IgG | 
| clonality | polyclonal | 
| concentration | 1 mg/mL | 
| applications | ICC/IF, WB | 
| reactivity | DcR1 (ED) | 
| available sizes | 100 µg | 
rabbit anti-DcR1 (ED) polyclonal antibody 7001
$445.00
Antibody summary
- Rabbit polyclonal to DcR1 (ED)
- Suitable for: ELISA,WB,ICC,IF
- Isotype: IgG
- 100 µg
rabbit anti-DcR1 (ED) polyclonal antibody 7001
| antibody | 
|---|
| Tested applications WB,ICC/IF,ELISA | 
| Recommended dilutions Immunoblotting: use at 1ug/mL. Immunocytochemistry: use at 10ug/mL. These are recommended concentrations. Enduser should determine optimal concentrations for their applications. Positive control: Whole cell lysate from HeLa cells. | 
| Immunogen Peptide corresponding to aa 149- 167 at the extracellular domain (ED) of human DcR1 precursor (accession no. AF012536). | 
| Size and concentration 100µg and lot specific | 
| Form liquid | 
| Storage Instructions This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze-thaw cycles. | 
| Storage buffer PBS, pH 7.4. | 
| Purity peptide affinity purification | 
| Clonality polyclonal | 
| Isotype IgG | 
| Compatible secondaries goat anti-rabbit IgG, H&L chain specific, peroxidase conjugated, conjugated polyclonal antibody 9512 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody 2079 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody 7863 goat anti-rabbit IgG, H&L chain specific, Cross Absorbed polyclonal antibody 2371 goat anti-rabbit IgG, H&L chain specific, biotin conjugated polyclonal antibody, crossabsorbed 1715 goat anti-rabbit IgG, H&L chain specific, FITC conjugated polyclonal antibody, crossabsorbed 1720 | 
| Isotype control Rabbit polyclonal - Isotype Control | 
| target relevance | 
|---|
| Protein names Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1) (DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3) (TRAIL receptor 3) (TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263) | 
| Gene names TNFRSF10C,TNFRSF10C DCR1 LIT TRAILR3 TRID UNQ321/PRO366 | 
| Mass 27407Da | 
| Function FUNCTION: Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand. | 
| Subellular location SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor. | 
| Tissues TISSUE SPECIFICITY: Higher expression in normal tissues than in tumor cell lines. Highly expressed in peripheral blood lymphocytes, spleen, skeletal muscle, placenta, lung and heart. | 
| Post-translational modification PTM: N-glycosylated and O-glycosylated. | 
| Target Relevance information above includes information from UniProt accession: O14798 | 
| The UniProt Consortium | 
Data
| No results found | 
Publications
| pmid | title | authors | citation | 
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Protocols
| relevant to this product | 
|---|
| Western blot IHC ICC | 
Documents
| # | SDS | Certificate | |
|---|---|---|---|
| Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. | |||
Only logged in customers who have purchased this product may leave a review.










Reviews
There are no reviews yet.